The “sex gap” in COVID-19 trials: a scoping review
Research article
[키워드] analyses
Analysis
antimalarial
Antiviral
Care
Case series
clinical trials
collected
convalescent plasma
Corona
Corticosteroid
COVID-19
COVID-19 patients
disease course
Diversity
drugs
eligible
Favipiravir
females
finding
for inclusion
funding
Genetic
genetics
higher fatality rate
Human
hydroxychloroquine/chloroquine
IL-1
IL-6
immune system
immunological
immunological responses
include
inhibitor
interleukin-6
investigated
male
mechanism
mechanisms
medRxiv
Modification
modulating
observational study
pathway
performed
pharmacological
pharmacological treatment
post-hoc
post-hoc analysis
Prophylactic
proportion
Randomized controlled trials
Remdesivir
reported
searched
Sex
Sex difference
Stratification
stratified
therapeutic
therapy
therapy for COVID-19
umifenovir
underlie
UpToDate
was performed
[DOI] 10.1016/j.eclinm.2020.100652 [Article Type] Research article
[DOI] 10.1016/j.eclinm.2020.100652 [Article Type] Research article